Next Article in Journal
Investigating the Role of Circulating miRNAs as Biomarkers in Colorectal Cancer: An Epidemiological Systematic Review
Previous Article in Journal
Two Loci Contribute to Age-Related Hearing Loss Resistance in the Japanese Wild-Derived Inbred MSM/Ms Mice
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Relationship between Maternal Fever and Neonatal Sepsis: A Retrospective Study at a Medical Center

1
Department of Neonatology, Changhua Christian Children’s Hospital, Changhua 50050, Taiwan
2
Big Data Center, Changhua Christian Hospital, Changhua 50050, Taiwan
3
Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung 40705, Taiwan
4
School of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan
*
Author to whom correspondence should be addressed.
Biomedicines 2022, 10(9), 2222; https://doi.org/10.3390/biomedicines10092222
Submission received: 21 July 2022 / Revised: 1 September 2022 / Accepted: 5 September 2022 / Published: 7 September 2022
(This article belongs to the Section Microbiology in Human Health and Disease)

Abstract

:
Various risk factors are associated with neonatal sepsis; however, its relationship to maternal postpartum fever is unknown. This study aimed to determine the relationship between maternal postpartum fever and neonatal sepsis. Full-term and late preterm stable infants born from January 2019 to June 2021 and whose mothers developed intra- or post-partum fever were included in the study. After the newborns were transferred to the nursery, laboratory assessments were performed. Based on clinical conditions and data, the newborns were divided into unlikely sepsis and probable/proven sepsis groups. Maternal fever onset, duration, and maximum body temperature were recorded. We included 1059 newborns whose mothers developed fever intra-partum (n = 192), post-partum (n = 844), and intra- and post-partum (n = 23). The newborns were grouped into those with unlikely sepsis (n = 550) and those with probable/proven sepsis (n = 509). The incidence of intrapartum fever was higher in the probable/proven sepsis group than in the unlikely sepsis group (27.9% vs. 13.3%, p < 0.001). The incidence of postpartum fever was lower in the probable/proven sepsis group than in the unlikely sepsis group (74.7% vs. 88.5%, p < 0.001). Development of maternal fever within 1.8 h postpartum and a newborn respiratory rate of >60 breaths/min were positive predictors (91.6%) for neonatal probable/proven sepsis.

1. Introduction

Neonatal sepsis is an important cause of morbidity and mortality. It ranks third among the causes of neonatal death, following prematurity and intrapartum-related complications [1,2]. Based on the timing of presentation, neonatal sepsis is classified as early or late onset. Early-onset neonatal sepsis presents clinical manifestations within the first 3 days of life (<72 h). Some researchers consider early-onset neonatal sepsis to occur in the first 7 days of life [3]. The incidence of early-onset neonatal sepsis ranges from 1 to 5 per 1000 live births. It has been shown to decrease with intrapartum antibiotic therapy [4,5].
Early-onset infection is usually due to vertical transmission by ascending contaminated amniotic fluid or during vaginal delivery from bacteria in the mother’s lower genital tract [6]. Various maternal risk factors are related to early-onset neonatal sepsis, and intrapartum maternal fever is one of them [6,7,8,9,10]. However, no previous study has explored the relationship between maternal postpartum fever and neonatal sepsis. The time of maternal fever onset, including intrapartum and postpartum, may indicate a variation in the risk of neonatal sepsis. Thus, evaluating neonatal sepsis in cases with maternal postpartum fever may be warranted. Therefore, this study aimed to determine the relationship between maternal postpartum and intrapartum fever and early-onset neonatal sepsis. Other relevant factors are compared with neonatal sepsis, including the time point of the maternal fever (intrapartum and postpartum), fever duration, maximum body temperature, delivery method, presence of chorioamnionitis, premature rupture of membrane (>18 h), misoprostol use, epidural analgesia use, and Apgar score.

2. Materials and Methods

2.1. Study Population

Owing to the retrospective nature of the study, the need for informed consent was waived.
We collected data on infants born at Changhua Christian Children’s Hospital Changhua, Taiwan from January 2019 to June 2021. The babies were born at more than 35 weeks gestation and weighed >2200 g. They were in a relatively stable condition at birth. Their mothers developed fever (body temperature ≥ 38 °C) during or after delivery. The mothers’ information was also collected at birth.

2.2. Data Collected from the Newborns

The newborns were transferred to the nursery for blood sampling after birth. Complete blood count and differential count, C-reactive protein measurement, and blood culture were performed. The sample volume of the blood culture was 1 mL [6]. Other collected data were sex, gestational age, birth weight, Apgar score at birth, time from birth to blood sampling, and vital signs including body temperature, heart rate, and respiratory rate.

2.3. Data Collected from the Mothers

The data collected from the mothers included age, parity, delivery method, prenatal group B streptococcus test result, premature rupture of membrane (PROM) (<18 h or ≥18 h), misoprostol use (to induce labor before childbirth or to stop bleeding after childbirth), epidural analgesia use, presence of chorioamnionitis, the time point of the maternal fever (before or after child birth), duration of maternal fever, and highest maternal body temperature. The definition of intrapartum in our study is from the onset of labor through the delivery of the baby. The definition of postpartum in our study is from birth to 48 h after birth. The fever duration is defined as the time when the body temperature rose above 38 °C to the time when the body temperature dipped below 38 °C. If fever subsided for 24 h, and then flared up again, it will be defined as two fever episodes. We choose the longer time as our fever duration. If one is intrapartum fever and the other is postpartum fever, both will be listed in our data. The definition of chorioamnionitis is maternal fever > 38 °C (100.4 degrees F) plus ≥ 1 of the following conditions, according to the American College of Obstetricians and Gynecologists (ACOG) recommendations:
Maternal tachycardia (pulse > 100 beats/minute for 5 min);
Fetal tachycardia (heart rate ≥ 160 beats/minute for 5 min);
Uterine tenderness;
Foul-smelling amniotic fluid;
Maternal leukocytosis (> 15,000–18,000 cells/mm3).
Intrapartum antibiotics administrated due to a positive or uncertain GBS screen result; Screen result and intrapartum fever was recorded.

2.4. Diagnosis

Based on their clinical symptoms and blood test results, we divided the newborns into two groups: those with unlikely sepsis and those with probable or proven sepsis. A positive blood culture result indicated proven sepsis, whereas a negative finding with clinical symptoms (e.g., ongoing temperature instability, shortness of breath, chest wall retraction, desaturation, or neurologic symptoms not explained by other conditions) or abnormal laboratory data findings (white blood cell count <5000/μL or white blood cell count 6 h after birth >32,000/μL, absolute neutrophil count <1000/μL, C-reactive protein >1 mg/dL, ratio of immature to total neutrophil count >20% [11,12,13,14,15,16]) indicated probable sepsis. The rest of the newborns were included in the unlikely sepsis group.

2.5. Statistical Analysis

Continuous variables are presented as the median and interquartile range (25th–75th percentile), and categorical variables are presented as number and percentage. The Mann–Whitney U, chi-square, or Fisher’s exact tests were performed, as appropriate, to determine whether variables were different between the two groups (unlikely and probable/proven sepsis). A receiver operating characteristic (ROC) curve analysis was conducted to evaluate the diagnostic performance of the first onset of maternal fever and the infant’s respiratory rate in predicting neonatal probable/proven sepsis, and the Youden index was used to determine the cutoff point. Bivariable and multivariable logistic regression analyses were performed to identify potential risk factors for neonatal probable/proven sepsis. All data were analyzed using SPSS for Windows (version 22.0, IBM Corp., Armonk, NY, USA). Statistical significance was set at p < 0.05.

3. Results

A total of 1059 newborns born in a hospital between January 2019 to June 2021 were included. The mothers developed fevers before delivery (n = 192), after delivery (n = 844), and before and after delivery (n = 23). Table 1 shows the two sample groups; namely, unlikely sepsis (n = 550) and probable/proven sepsis (n = 509). The Mann–Whitney U test was used to compare the differences between the two groups. The factors that showed significant differences in distribution between the two groups were parity, time from postpartum misoprostol administration to fever onset, time from birth to fever onset, time point of the first maternal fever, gestational age, birth weight, 1 min Apgar score, time of data from infant birth, infant heart rate, and infant respiratory rate. Among the 1059 newborns, four had bacteremia. The time points of the maternal fever and microorganism confirmation are shown in Table 2. Among the newborns with bacteremia, three had mothers who developed fever after delivery, and two had blood cultures positive for Escherichia coli and Streptococcus agalactiae, which are commonly associated with early-onset neonatal sepsis [17,18,19].
Table 3 shows the relationship between perinatal factors and neonatal sepsis. We used the chi-square or Fisher’s exact tests to compare the differences between the two groups. The incidence of risk factors in the probable/proven sepsis group was higher than that in the unlikely sepsis group; the results will provide relevant figures from the probable/proven sepsis and unlikely sepsis groups, respectively. The number of parities was mostly one (76.2% vs. 66.4%, p = 0.004), and the delivery method was mainly vacuum extraction delivery (VED) (60.7% vs. 46.7%, p < 0.001). The time point of misoprostol use was before delivery (34.8% vs. 25.6%, p = 0.005), and the rate of epidural analgesia use was higher (82.1% vs. 60.4%, p < 0.001). Moreover, less prematurity (6.3% vs. 13.5%, p < 0.001), more newborns with premature rupture of membranes over 18 h (8.4% vs. 3.1%, p < 0.001), and more newborns with 1 min Apgar score <7 (2.6% vs. 0.5%, p = 0.01) were observed. The incidence of intrapartum fever (38–38.9 °C) (27.9% vs. 13.3%, p < 0.001) and high fever (≥39 °C) (5.7% vs. 2.2%, p = 0.003) was higher in the probable/proven sepsis group than that in the unlikely sepsis group. Postpartum fever was more common in the unlikely sepsis group (88.5% vs. 74.7%, p < 0.001).
Table 4 shows the findings of the logistic regression analysis that was used to evaluate the correlation between perinatal factors and neonatal sepsis. In the bivariable analysis, probable/proven sepsis was significantly associated with the following perinatal factors: less parity (crude odds ratio = 0.681, 95% confidence interval (CI) = 0.553–0.839, p < 0.001), misoprostol use before delivery (crude odds ratio = 1.562, 95% CI = 1.166–2.094, p = 0.003), epidural analgesia use during delivery (crude odds ratio = 3.111, 95% CI = 2.333–4.149, p < 0.001), VED as main delivery method (crude odds ratio = 1.632, 95% CI = 1.177–2.262, p = 0.003), 1 min Apgar score <7 (crude odds ratio = 4.779, 95% CI = 1.354–16.869, p = 0.015), and PROM >18 (crude odds ratio = 2.893, 95% CI = 1.628–5.142, p < 0.001). The risk of neonatal sepsis was significantly lower for women with postpartum fever than for women with intrapartum fever (crude odds ratio = 0.376, 95% CI = 0.270–0.523, p < 0.001). After adjusting for possible confounding factors, the multivariable analysis still showed that maternal postpartum fever had a significantly lower risk of neonatal sepsis (adjusted odds ratio = 0.661, 95% CI = 0.439–0.994, p = 0.047).
We used an ROC curve to evaluate the diagnostic performance of the first maternal fever time point and the infant’s respiratory rate in predicting neonatal probable/proven sepsis. ROC analysis showed that the areas under the curve were 0.639 (95% CI = 0.605–0.672, p < 0.001) for first maternal fever time point alone, and 0.829 (95% CI = 0.804–0.853, p < 0.001) for first maternal fever time point combined with infant’s respiratory rate (Figure 1). When the time point of the first maternal fever was within 1.8 h postpartum and the newborn’s respiratory rate was >60 breaths/min, the positive predictive value was 91.6% for neonatal probable/proven sepsis.

4. Discussion

Our results showed that newborns whose mothers developed postpartum fever were at a significantly lower risk of acquiring neonatal sepsis compared with those whose mothers developed intrapartum fever. It is clear that not all fevers of women in labor or postpartum are caused by microbial organisms. We also found that when the mother developed fever within 1.8 h postpartum and the baby exhibited rapid breathing after birth (>60 breaths/min), the positive predictive value for neonatal sepsis was 91.6%. By contrast, in the newborns in the unlikely sepsis group, 97.5% (specificity) of the mothers developed the first fever 1.8 h postpartum or the neonatal respiratory rate was ≤60 breaths/min. The correlation between maternal postpartum fever and neonatal sepsis has not been reported. In our proven sepsis case, the mother of the newborn developed fever after delivery. The case exhibited E. coli and S. agalactiae infections, which are the most common causes of early-onset sepsis [17,18,19]. The mother of the newborn with E. coli infection was diagnosed with chorioamnionitis, and the endometrial culture was positive for E. coli. However, the mother did not develop fever until after childbirth. If a mother has an infection, it can be passed on to the newborn before the onset of the fever. Therefore, if a mother has a fever after childbirth, the newborn may still have been exposed to the infection. According to the CDC guidelines, “in an effort to avert neonatal infections, maternal fever alone in labor may be used as a sign of chorioamnionitis and the newborn should undergo a limited evaluation and receive antibiotic therapy pending culture results” [20]. Numerous studies have found a correlation between maternal intrapartum fever and neonatal sepsis [6,7,8,9,10]. Our statistical results showed no correlation between intrapartum fever duration and neonatal sepsis [9]; however, a significant correlation between high intrapartum fever (≥39 °C) and neonatal sepsis was observed, which is consistent with the results of other studies [9,10].
Many studies have reported that preterm infants have a higher risk of neonatal sepsis than full-term infants [21,22], and the risk of infection in newborns with low birth weight is also increased [21,22]. However, in our study, preterm infants were not associated with neonatal sepsis, and those with lower birth weight were instead included in the unlikely sepsis group. The possible reason for this may be because the included newborns were all >35 weeks old, weighed >2200 g, and were relatively stable at birth. The possibility of infection is judged based on the follow-up clinical manifestations and laboratory findings. Newborns with low gestational age and low birth weight may have been admitted to general wards or intensive care units at the beginning and thus were not included in our study, which probably caused the difference in our study results.
Our study showed that epidural analgesia is associated with neonatal sepsis, but not causal effect. Some studies reported that epidural analgesia and intrapartum fever are significantly correlated [23,24,25]. Although the patients included in our study were all mothers with intrapartum or postpartum fever, our results showed that intrapartum fever was associated with neonatal sepsis, which may indirectly indicate a correlation between epidural analgesia and neonatal sepsis [25]. The obstetrics and gynecology department of our hospital uses misoprostol to induce labor or treat postpartum hemorrhage. A common adverse effect of misoprostol is the onset of maternal fever [26,27]. Our research recorded the time point of misoprostol use, and statistical results showed that the timing of misoprostol for labor induction is related to neonatal infection, which may be associated with the relatively unstable condition of the mother or fetus.
Our study showed that nulliparous mothers were associated with neonatal sepsis more than multiparous mothers, and the literature showed that nulliparous women are associated with intrapartum fever. A possible explanation for fever among nulliparous mothers could be the higher energy expenditure associated with muscle contraction [28]. Therefore, we included more nulliparous women in our evaluation. Other studies have reported a higher rate of nulliparous women who received epidural analgesia [29]. Similar to intrapartum fever and epidural analgesia, nulliparity was also associated with neonatal sepsis in our study. Previous studies emphasized that in mothers with fever, instrumental and cesarean deliveries comprised the higher proportion of delivery methods [9,28]. Our study pointed to a significant association between VED and neonatal sepsis, possibly explained by a less smooth birth process or a less stable fetus, which may be due to infection. Premature rupture of the membranes (>18 h) was significantly associated with neonatal sepsis in our study, which is consistent with the results from other reports [6,7,8]. Maternal chorioamnionitis is a well-recognized risk factor for early-onset neonatal sepsis [7,30]. Chorioamnionitis and neonatal infection did not reach a statistical correlation in our study. This may be because neonates whose mothers were diagnosed with chorioamnionitis were directly admitted to the ward and were not included in our study because of the unstable clinical status of the infection at birth. Babies with a low 5 min Apgar score were at risk of acquiring neonatal sepsis [31,32]. The newborns we included were relatively stable at birth, with a 5 min Apgar score >7 after management. A low 1 min Apgar score was associated with neonatal sepsis in our study. This may be because newborns at risk of infection are born in relatively unstable condition, without management.
The limitation of this study is that we only included neonates in stable condition at birth. Patients who were directly admitted to the hospital in unstable condition should have been included for comparison.

5. Conclusions

Infants whose mothers’ first fever occurs within 1.8 h postpartum and whose respiratory rate is >60 times/min may be at risk for sepsis and may require further examination. By contrast, infants whose mothers’ first fever begins >1.8 h postpartum or whose respiratory rate is ≤60 times/min may be less likely to develop sepsis and may not need aggressive intervention.

Author Contributions

Methodology, Y.-J.C.; resources, C.-C.H.; supervision, L.-J.C., C.-H.L., H.-N.C. and J.-Y.C.; writing—original draft, S.-H.H.; writing—review and editing, C.-C.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki and approved by the Research Ethics Board Committee of Changhua Christian Children’s Hospital (CCH IRB No. 210903; approval date: 18 October 2021).

Informed Consent Statement

Owing to the retrospective nature of this study, the requirement for informed consent was waived.

Data Availability Statement

The data used for this study are available from a publicly accessible repository.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Liu, L.; Johnson, H.L.; Cousens, S.; Perin, J.; Scott, S.; Lawn, J.E.; Rudan, I.; Campbell, H.; Cibulskis, R.; Li, M.; et al. Global, Regional, and National Causes of Child Mortality: An Updated Systematic Analysis for 2010 With Time Trends Since 2000. Lancet 2012, 379, 2151–2161. [Google Scholar] [CrossRef]
  2. Oza, S.; Lawn, J.E.; Hogan, D.R.; Mathers, C.; Cousens, S.N. Neonatal Cause-of-Death Estimates for the Early and Late Neonatal Periods for 194 Countries: 2000–2013. Bull. World Health Organ. 2015, 93, 19–28. [Google Scholar] [CrossRef] [PubMed]
  3. American Academy of Pediatrics. Group B Streptococcal Infections. In Report of the Committee on Infectious Diseases, 31st ed.; Book, R., Kimberlin, D.W., Brady, M.T., Jackson, M.A., Long, S.S., Eds.; American Academy of Pediatrics: Itasca, IL, USA, 2018; p. 762. [Google Scholar]
  4. Centers for Disease Control and Prevention (CDC). Perinatal Group B Streptococcal Disease After Universal Screening Recommendations—United States, 2003–2005. MMWR Morb. Mortal. Wkly Rep. 2007, 56, 701–705. [Google Scholar]
  5. Centers for Disease Control and Prevention (CDC). Trends in Perinatal Group B Streptococcal Disease—United States, 2000–2006. MMWR Morb. Mortal. Wkly Rep. 2009, 58, 109–112. [Google Scholar]
  6. Puopolo, K.M.; Benitz, W.E.; Zaoutis, T.E.; Committee on Fetus and Newborn; Committee on Infectious Diseases. Management of Neonates Born at ≥35 0/7 Weeks’ Gestation with Suspected or Proven Early-Onset Bacterial Sepsis. Pediatrics 2018, 142, e20182894. [Google Scholar] [CrossRef]
  7. Escobar, G.J.; Li, D.K.; Armstrong, M.A.; Gardner, M.N.; Folck, B.F.; Verdi, J.E.; Xiong, B.; Bergen, R. Neonatal Sepsis Workups in Infants ≥ 2000 Grams at Birth: A Population-Based Study. Pediatrics 2000, 106, 256–263. [Google Scholar] [CrossRef]
  8. Puopolo, K.M.; Draper, D.; Wi, S.; Newman, T.B.; Zupancic, J.; Lieberman, E.; Smith, M.; Escobar, G.J. Estimating the Probability of Neonatal Early-Onset Infection on the Basis of Maternal Risk Factors. Pediatrics 2011, 128, e1155–e1163. [Google Scholar] [CrossRef] [PubMed]
  9. Ashwal, E.; Salman, L.; Tzur, Y.; Aviram, A.; Ben-Mayor Bashi, T.; Yogev, Y.; Hiersch, L. Intrapartum Fever and the Risk for Perinatal Complications—The Effect of Fever Duration and Positive Cultures. J. Matern. Fetal Neonatal Med. 2018, 31, 1418–1425. [Google Scholar] [CrossRef] [PubMed]
  10. Dior, U.P.; Kogan, L.; Eventov-Friedman, S.; Gil, M.; Bahar, R.; Ergaz, Z.; Porat, S.; Calderon-Margalit, R. Very High Intrapartum Fever in Term Pregnancies and Adverse Obstetric and Neonatal Outcomes. Neonatology 2016, 109, 62–68. [Google Scholar] [CrossRef]
  11. Hornik, C.P.; Benjamin, D.K.; Becker, K.C.; Benjamin, D.K., Jr.; Li, J.; Clark, R.H.; Cohen-Wolkowiez, M.; Smith, P.B. Use of the Complete Blood Cell Count in Early-Onset Neonatal Sepsis. Pediatr. Infect. Dis. J. 2012, 31, 799–802. [Google Scholar] [CrossRef]
  12. Murphy, K.; Weiner, J. Use of Leukocyte Counts in Evaluation of Early-Onset Neonatal Sepsis. Pediatr. Infect. Dis. J. 2012, 31, 16–19. [Google Scholar] [CrossRef] [PubMed]
  13. Iroh Tam, P.Y.I.; Bendel, C.M. Diagnostics for Neonatal Sepsis: Current Approaches and Future Directions. Pediatr. Res. 2017, 82, 574–583. [Google Scholar] [CrossRef]
  14. Saboohi, E.; Saeed, F.; Khan, R.N.; Khan, M.A. Immature to Total Neutrophil Ratio as an Early Indicator of Early Neonatal Sepsis. Pak. J. Med. Sci. 2019, 35, 241–246. [Google Scholar] [CrossRef]
  15. Monica, L.; Riti, J.S.; Amit, B.K. Role of Sepsis Screen Parameters in Early Diagnosis of Neonatal Septicemia. Int. J. Curr. Microbiol. App. Sci. 2018, 7, 2410–2419. [Google Scholar] [CrossRef]
  16. Newman, T.B.; Puopolo, K.M.; Wi, S.; Draper, D.; Escobar, G.J. Interpreting Complete Blood Counts Soon After Birth in Newborns at Risk for Sepsis. Pediatrics 2010, 126, 903–909. [Google Scholar] [CrossRef]
  17. Kuhn, P.; Dheu, C.; Bolender, C.; Chognot, D.; Keller, L.; Demil, H.; Donato, L.; Langer, B.; Messer, J.; Astruc, D. Incidence and Distribution of Pathogens in Early-Onset Neonatal Sepsis in the Era of Antenatal Antibiotics. Paediatr. Perinat. Epidemiol. 2010, 24, 479–487. [Google Scholar] [CrossRef]
  18. Chacko, B.; Sohi, I. Early Onset Neonatal Sepsis. Indian J. Pediatr. 2005, 72, 23–26. [Google Scholar] [CrossRef]
  19. Stoll, B.J.; Puopolo, K.M.; Hansen, N.I.; Sánchez, P.J.; Bell, E.F.; Carlo, W.A.; Cotten, C.M.; D’Angio, C.T.; Kazzi, S.N.J.; Poindexter, B.B.; et al. Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies. JAMA Pediatr. 2020, 174, e200593. [Google Scholar] [CrossRef]
  20. Verani, J.R.; McGee, L.; Schrag, S.J.; Division of Bacterial Disease, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC). Prevention of Perinatal Group B Streptococcal Disease—Revised Guidelines From CDC, 2010. MMWR Recomm. Rep. 2010, 59, 1–36. [Google Scholar]
  21. Shane, A.L.; Sánchez, P.J.; Stoll, B.J. Neonatal Sepsis. Lancet 2017, 390, 1770–1780. [Google Scholar] [CrossRef]
  22. Belachew, A.; Tewabe, T. Neonatal Sepsis and Its Association with Birth Weight and Gestational Age Among Admitted Neonates in Ethiopia: Systematic Review and Meta-analysis. BMC Pediatr. 2020, 20, 55. [Google Scholar] [CrossRef] [PubMed]
  23. Sharpe, E.E.; Arendt, K.W. Epidural Labor Analgesia and Maternal Fever. Clin. Obstet. Gynecol. 2017, 60, 365–374. [Google Scholar] [CrossRef] [PubMed]
  24. Jansen, S.; Lopriore, E.; Naaktgeboren, C.; Sueters, M.; Limpens, J.; van Leeuwen, E.; Bekker, V. Epidural-Related Fever and Maternal and Neonatal Morbidity: A Systematic Review and Meta-analysis. Neonatology 2020, 117, 259–270. [Google Scholar] [CrossRef]
  25. Wassen, M.M.; Winkens, B.; Dorssers, E.M.; Marcus, M.A.; Moonen, R.M.; Roumen, F.J. Neonatal Sepsis Is Mediated by Maternal Fever in Labour Epidural Analgesia. J. Obstet. Gynaecol. 2014, 34, 679–683. [Google Scholar] [CrossRef]
  26. Nijman, T.A.J.; Voogdt, K.G.J.A.; Teunissen, P.W.; van der Voorn, P.J.J.; de Groot, C.J.M.; Bakker, P.C.A.M. Association Between Infection and Fever in Terminations of Pregnancy Using Misoprostol: A Retrospective Cohort Study. BMC Pregnancy Childbirth 2017, 17, 7. [Google Scholar] [CrossRef] [PubMed]
  27. León, W.; Durocher, J.; Barrera, G.; Pinto, E.; Winikoff, B. Dose and Side Effects of Sublingual Misoprostol for Treatment of Postpartum Hemorrhage: What Difference Do They Make? BMC Pregnancy Childbirth 2012, 12, 65. [Google Scholar] [CrossRef]
  28. Maayan-Metzger, A.; Mazkereth, R.; Shani, A.; Kuint, J. Risk Factors for Maternal Intrapartum Fever and Short-Term Neonatal Outcome. Fetal Pediatr. Pathol. 2006, 25, 169–177. [Google Scholar] [CrossRef] [PubMed]
  29. Yancey, M.K.; Zhang, J.; Schwarz, J.; Dietrich, C.S., 3rd; Klebanoff, M. Labor Epidural Analgesia and Intrapartum Maternal Hyperthermia. Obstet. Gynecol. 2001, 98, 763–770. [Google Scholar] [CrossRef] [PubMed]
  30. Alexander, J.M.; McIntire, D.M.; Leveno, K.J. Chorioamnionitis and the Prognosis for Term Infants. Obstet. Gynecol. 1999, 94, 274–278. [Google Scholar] [CrossRef]
  31. G./Eyesus, T.; Moges, F.; Eshetie, S.; Yeshitela, B.; Abate, E. Bacterial Etiologic Agents Causing Neonatal Sepsis and Associated Risk Factors in Gondar, Northwest Ethiopia. BMC Pediatr. 2017, 17, 137. [Google Scholar] [CrossRef]
  32. Sorsa, A. Epidemiology of Neonatal Sepsis and Associated Factors Implicated: Observational Study at Neonatal Intensive Care Unit of Arsi University Teaching and Referral Hospital, South East Ethiopia. Ethiop. J. Health Sci. 2019, 29, 333–342. [Google Scholar] [CrossRef] [PubMed]
Figure 1. ROC curve to predict whether the baby has probable/proven sepsis based on the time point of the mother’s first fever (baby birth time as the origin) and infant’s respiratory rate. PPV, positive predictive value; NPV, negative predictive value; LR+, likelihood ratio for a positive test; LR−, likelihood ratio for a negative test; AUC, area under curve; SE, standard error; CI, confidence interval; hr, hour; min, minute.
Figure 1. ROC curve to predict whether the baby has probable/proven sepsis based on the time point of the mother’s first fever (baby birth time as the origin) and infant’s respiratory rate. PPV, positive predictive value; NPV, negative predictive value; LR+, likelihood ratio for a positive test; LR−, likelihood ratio for a negative test; AUC, area under curve; SE, standard error; CI, confidence interval; hr, hour; min, minute.
Biomedicines 10 02222 g001
Table 1. Relationship between perinatal factors and neonatal sepsis.
Table 1. Relationship between perinatal factors and neonatal sepsis.
Unlikely Sepsis (n = 550)Probable/Proven (n = 509)p-Value
MedianQ1Q3MedianQ1Q3
Maternal Factors
Age
Parity
Prenatal misoprostol administration to fever time (h)
Postpartum misoprostol administration to fever time (h)
Prenatal epidural analgesia to fever time (h)
Fever to birth time (h)
From birth to fever time (h)
Time point of first fever (h) (birth time as origin)
Baby’s Factors
Gestational age (week)
Birth body weight (g)
1 min APGAR score
Time of data from birth (h)
Heart rate (beats/min)
Respiratory rate (breaths/min)

32.00
1.00
17.98
2.25
13.33
3.75
2.75
2.58

38.71
2989.00
8.00
3.37
152.00
55.00

29.00
1.00
10.47
1.50
8.28
1.37
2.08
1.52

37.71
2694.00
8.00
2.38
144.00
51.00

36.00
2.00
28.92
2.78
21.33
10.13
3.63
3.43

39.43
3254.00
8.00
4.75
158.00
58.00

32.00
1.00
17.44
1.81
14.42
3.41
2.40
1.77

38.86
3122.00
8.00
2.82
160.00
62.00

28.00
1.00
11.85
1.25
8.29
1.32
1.55
−0.63

38.00
2850.00
8.00
1.97
156.00
58.00

35.00
1.00
26.58
2.67
23.27
8.27
3.13
2.78

39.57
3378.00
8.00
3.97
163.00
66.00

0.175
<0.001
0.926
0.008
0.170
0.514
<0.001
<0.001

0.001
<0.001
0.001
<0.001
<0.001
<0.001
Q1, percentile 25; Q3, percentile 75; SD, standard deviation; h, hour; g, gram; min, minute. p-value from Mann–Whitney U Test.
Table 2. Maternal fever time point and bacteremia.
Table 2. Maternal fever time point and bacteremia.
MicroorganismMaternal Fever Time PointTime Interval between Fever and Birth (Min)
Case 1Escherichia colipostpartum fever149
Case 2Streptococcus agalactiaepostpartum fever142
Case 3Streptococcus gallolyticus ssp pasteurianusintrapartum fever29
Case 4Bacillus cereus grouppostpartum fever241
Min: minutes.
Table 3. Relationship between perinatal factors and neonatal sepsis.
Table 3. Relationship between perinatal factors and neonatal sepsis.
UnlikelyProbable/Provenp-Value
n (550)%n (509)%
Parity1
2
3
4
5
365
149
29
6
1
66.4
27.1
5.3
1.1
0.2
338
102
17
2
0
76.2
20.0
3.3
0.4
0.0
0.004
Delivery typeNSD
C/S
VED
114
179
257
20.7
32.5
46.7
84
116
309
16.5
22.8
60.7
<0.001
GBS screenNegative
Positive
Unknown
410
120
20
74.5
21.8
3.6
397
102
10
78.0
20.0
2.0
0.181
ChorioamnionitisNo
Suspected
Yes
543
6
0
98.9
1.1
0
496
9
4
97.4
1.8
0.8
0.076
Time point of MisoprostolNo use
Before delivery
After delivery
Use after fever
234
141
163
12
42.5
25.6
29.6
2.2
188
177
127
17
36.9
34.8
25.0
3.3
0.005
Epidural analgesia in laborNo
Yes
Use after fever
215
332
3
39.1
60.4
0.5
87
418
4
17.1
82.1
0.8
<0.001
Intrapartum fever (38–38.9 °C)No
Yes
477
73
86.7
13.3
367
142
72.1
27.9
<0.001
Fever duration—intrapartum<4 h
4–8 h
8–12 h
>12 h
40
18
9
6
54.8
24.7
12.3
8.2
86
25
17
14
60.6
17.6
12.0
9.9
0.656
Intrapartum fever (≥39 °C)No
Yes
538
12
97.8
2.2
480
29
94.3
5.7
0.003
Postpartum fever (38–38.9 °C)No
Yes
63
487
11.5
88.5
129
380
25.3
74.7
<0.001
Fever duration—postpartum<4 h
4–8 h
8–12 h
>12 h
410
62
8
7
84.2
12.7
1.6
1.4
321
44
7
8
84.5
11.6
1.8
2.1
0.842
Postpartum fever (≥39 °C)No
Yes
465
85
84.5
15.5
451
58
88.6
11.4
0.053
PretermNo
Yes
476
74
86.5
13.5
477
32
93.7
6.3
<0.001
APGAR score −1 min≥7
<7
547
3
99.5
0.5
496
13
97.4
2.6
0.010
PROM > 18 hNo
Yes
533
17
96.9
3.1
466
43
91.6
8.4
<0.001
Fever time pointIntrapartum
Postpartum
Intra- and postpartum
63
477
10
11.5
86.7
1.8
129
367
13
25.3
72.1
2.6
<0.001
NSD, normal spontaneous delivery; C/S, cesarean section; VED, vacuum extract-delivery; PROM, premature rupture of membrane. p-value from chi-square or Fisher’s exact tests, as appropriate.
Table 4. Logistic regression analysis of probable or proven neonatal sepsis.
Table 4. Logistic regression analysis of probable or proven neonatal sepsis.
Bivariable Analysis (Crude)Multivariable Analysis (Adjusted)
Odds Ratio95% CIp-ValueOdds Ratio95% CIp-Value
Parity0.6810.553–0.839<0.001
Time point of Misoprostol
No use
Before delivery
After delivery
Use after fever

1.000
1.562
0.970
1.763


1.166–2.094
0.718–1.311
0.822–3.784


0.003
0.842
0.145
Epidural analgesia in labor
No
Yes
Use after fever

1.000
3.111
3.295


2.333–4.149
0.722–15.028


<0.001
0.124

1.000
3.398
2.177


2.355–4.902
0.352–13.468


<0.001
0.403
Delivery type
NSD
C/S
VED

1.000
0.879
1.632


0.610–1.268
1.177–2.262


0.492
0.003
Intrapartum fever (38–38.9°C)
No
Yes

1.000
2.528


1.848–3.459


<0.001
Maternal fever time point
Intrapartum
Postpartum
Intra- and post-partum fever

1.000
0.376
0.635


0.270–0.523
0.264–1.527


<0.001
0.310

1.000
0.661
0.969


0.439–0.994
0.341–2.750


0.047
0.953
APGAR score −1 min
≥7
<7

1.000
4.779


1.354–16.869


0.015
PROM >18 h
No
Yes

1.000
2.893


1.628–5.142


<0.001
Heart rate1.1481.125–1.172<0.001
Respiratory rate1.2351.200–1.270<0.0011.2301.194–1.267<0.001
CI, confidence interval; NSD, normal spontaneous delivery; C/S, cesarean section; VED, vacuum extract-delivery; PROM, premature rupture of membrane.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Huang, S.-H.; Chang, Y.-J.; Chen, L.-J.; Lee, C.-H.; Chen, H.-N.; Chen, J.-Y.; Hsiao, C.-C. Relationship between Maternal Fever and Neonatal Sepsis: A Retrospective Study at a Medical Center. Biomedicines 2022, 10, 2222. https://doi.org/10.3390/biomedicines10092222

AMA Style

Huang S-H, Chang Y-J, Chen L-J, Lee C-H, Chen H-N, Chen J-Y, Hsiao C-C. Relationship between Maternal Fever and Neonatal Sepsis: A Retrospective Study at a Medical Center. Biomedicines. 2022; 10(9):2222. https://doi.org/10.3390/biomedicines10092222

Chicago/Turabian Style

Huang, Sheng-Hua, Yu-Jun Chang, Lih-Ju Chen, Cheng-Han Lee, Hsiao-Neng Chen, Jia-Yuh Chen, and Chien-Chou Hsiao. 2022. "Relationship between Maternal Fever and Neonatal Sepsis: A Retrospective Study at a Medical Center" Biomedicines 10, no. 9: 2222. https://doi.org/10.3390/biomedicines10092222

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop